Vaccine Acceptance in Pregnant Minority Women
- Conditions
- Pregnancy
- Interventions
- Behavioral: Maternal Vaccine Education
- Registration Number
- NCT01740310
- Lead Sponsor
- Emory University
- Brief Summary
The purpose of study will be to test two vaccine education strategies to learn how they impact flu and pertussis (Tdap) vaccination rates and attitudes regarding vaccination during pregnancy after participating in the intervention. The education strategies will be based on the elaboration likelihood model (ELM). This model is based on experimental psychology and has been previously used to increase breast cancer screening rates. These education strategies will be delivered through routine prenatal care visits to black/African-American women in Atlanta.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 121
- Pregnant, expecting delivery between August 31, 2012 and June 30, 2013
- Between the ages of 18-50 years old
- Black/African American
- Have received the influenza or Tdap vaccine during the current pregnancy
- Already enrolled in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description High Elaboration Interactive Tutorial Arm Maternal Vaccine Education Women will be exposed to a handheld/electronic tablet device-based intervention designed to invoke a high level of attention to the message and thought (elaboration) while processing information through an interactive question/answer format. Low Elaboration / Control Arm Maternal Vaccine Education Women randomized to the control arm will be provided standard CDC vaccine information statements that will likely lead to low elaboration information processing. High Elaboration Video Arm Maternal Vaccine Education Women randomized to this arm will be exposed to a handheld/electronic tablet device-based video with detailed vaccine-related information designed to invoke a high level of attention to the message and thought (elaboration) while processing information.
- Primary Outcome Measures
Name Time Method Influenza vaccination rates in pregnancy Baseline and one month after participant's expected date of delivery Data on vaccination status will be collected from participants enrolled in the main phase of the study during follow up starting one month after the expected date of delivery. We will contact healthcare providers to obtain vaccination records for those who provide written consent to release their immunization records.
- Secondary Outcome Measures
Name Time Method Tdap vaccination rates in pregnancy Baseline and one month after participant's expected date of delivery Data on vaccination status will be collected from participants enrolled in the main phase of the study during follow up starting one month after the expected date of delivery. We will contact healthcare providers to obtain vaccination records for those who provide written consent to release their immunization records.
Change in attitudes regarding vaccination Baseline and one month after the expected date of delivery Data on attitudes regarding vaccination status will be collected from participants enrolled in the main phase of the study during follow up starting one month after the expected date of delivery.
Trial Locations
- Locations (4)
Grady Health System
🇺🇸Atlanta, Georgia, United States
Emory University Hospital Midtown
🇺🇸Atlanta, Georgia, United States
Dourron OB/Gyn Associates Clinic
🇺🇸Decatur, Georgia, United States
New Millenium Obstetrics & Gynecology
🇺🇸Riverdale, Georgia, United States